Swamp Notes: Trump tries to bring watchdogs to heel
FT News Briefing
00:00
The Dilemma of Deregulation: Risks and Rewards in Business
This chapter delves into the effects of reduced regulation in the financial and pharmaceutical sectors, analyzing both the potential short-term benefits for bank stocks and the long-term risks to drug approval processes. It highlights the paradox of businesses desiring stability while potentially facing greater uncertainty in a deregulated landscape.
Transcript
Play full episode
